COVID-19 SÜRECİNDE DİŞHEKİMLİĞİ UYGULAMALARI

Öz

Etiyolojisi bilinmeyen bir pnömoni salgını Çin'in Hubei eyaleti Wuhan Şehrinde bir deniz ürünleri pazarında Aralık 2019'da ortaya çıktı ve hızla Çin'in diğer eyaletlerine ve diğer Dünya ülkelerine yayılım gösterdi. Yeni tip bir koronavirüs (SARS-CoV-2) etken ajan olarak tanımlandı ve bu etkenin yol açtığı hastalık Dünya Sağlık Örgütü (WHO) tarafından koronavirüs hastalığı COVID-19 olarak adlandırıldı. COVID-19 'un dünya çapındaki şiddetli ve hızlı yayılımından dolayı Dünya Sağlık Örgütü tarafından 11 Mart 2020'de pandemi ilan edildi. Dünya'nın bir çok ülkesinde hastalığın yayılımını önlemek için tedbirler alınmaya başlandı. COVID-19 öksürük, hapşırma, damlacık inhalasyonu yoluyla direk olarak bulaşırken, ağız, burun ve göz mukozalarıyla da temas yoluyla bulaşmaktadır. Dişhekimliği uygulamalarının büyük çoğunluğunda tükürük, kan ve aerosol / damlacık üretimine maruz kalınması nedeniyle COVID 19 'un yayılımında yüksek risk teşkil etmektedir. Bu nedenle salgından etkilenen bir çok ülkede dental uygulamalar ya tamamıyla durmuş ya da sadece acil uygulamalar gerçekleştirilecek şekilde minimale indirilmiştir. Bu derlemede koronavirüs hastalığının özellikleri ve dental tedaviler sırasında oluşabilecek enfeksiyon yayılımını kontrol altına almak için alınabilecek önlemler ele alınacaktır.

Anahtar Kelimeler

• COVID-19
• Dişhekimliği
• Pandemi

Kaynakça

1. 1. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol. 2020;92(4):401-2.
2. 2. Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020;76:71-6.
3. 3. Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: challenges for global health governance. Jama. 2020;323(8):709-10.
4. 4. Mahase E. China coronavirus: WHO declares international emergency as death toll exceeds 200. Bmj. 2020;368:m408.
5. 5. Organization WH. Coronavirus disease 2019 (COVID-19): situation report, 67. 2020.
6. 6. Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet. 2020;395(10223):514-23.
7. 7. Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B. Transmission routes of 2019-nCoV and controls in dental practice. International Journal of Oral Science. 2020;12(1):1-6.
8. 8. Fan Y, Zhao K, Shi Z-L, Zhou P. Bat Coronaviruses in China. Viruses. 2019;11(3):210.

9. 9. Gorbalenya AE. Severe acute respiratory syndrome-related coronavirus–The species and its viruses, a statement of the Coronavirus Study Group. BioRxiv. 2020.
10. 10. Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nature reviews Microbiology. 2019;17(3):181-92.
11. 11. Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. nature. 2020;579(7798):270-3.
12. 12. Li J-Y, You Z, Wang Q, Zhou Z-J, Qiu Y, Luo R, et al. The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future. Microbes and Infection. 2020;22(2):80-5.
13. 13. Del Rio C, Malani PN. 2019 Novel coronavirus—important information for clinicians. Jama. 2020;323(11):1039-40.
14. 14. Lu C-w, Liu X-f, Jia Z-f. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet (London, England). 2020;395(10224):e39.
15. 15. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020;395(10223):497-506.
16. 16. To KK-W, Tsang OT-Y, Yip CC-Y, Chan K-H, Wu T-C, Chan JM-C, et al. Consistent detection of 2019 novel coronavirus in saliva. Clinical Infectious Diseases. 2020.
17. 17. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. New England Journal of Medicine. 2020;382(10):970-1.
18. 18. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. New England Journal of Medicine. 2020.
19. 19. Nicola M, O’Neill N, Sohrabi C, Khan M, Agha M, Agha R. Evidence Based Management Guideline for the COVID-19 Pandemic-Review article. International Journal of Surgery. 2020.
20. 20. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal of Medicine. 2020.
21. 21. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507-13.
22. 22. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. The Lancet infectious diseases. 2013;13(9):752-61.
23. 23. Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, et al. Clinical characteristics of 2019 novel coronavirus infection in China. MedRxiv. 2020.
24. 24. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020;323(11):1061-9.
25. 25. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet. 2020;395(10226):809-15.
26. 26. Liu K, Fang Y-Y, Deng Y, Liu W, Wang M-F, Ma J-P, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chinese medical journal. 2020.
27. 27. Yang Y, Lu Q, Liu M, Wang Y, Zhang A, Jalali N, et al. Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. MedRxiv. 2020.
28. 28. Li T, Wei C, Li W, Hongwei F, Shi J. Beijing Union Medical College Hospital on" pneumonia of novel coronavirus infection" diagnosis and treatment proposal (V2. 0). Med J Peking Union Med Coll Hosp. 2020.
29. 29. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. New England Journal of Medicine. 2020.
30. 30. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive care medicine. 2017;43(3):304-77.
31. 31. Chu C, Cheng V, Hung I, Wong M, Chan K, Chan K, et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59(3):252-6.
32. 32. Gamio L. The workers who face the greatest coronavirus risk. New York Times. 2020.
33. 33. Liu L, Wei Q, Alvarez X, Wang H, Du Y, Zhu H, et al. Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques. Journal of virology. 2011;85(8):4025-30.
34. 34. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. Journal of Hospital Infection. 2020.
35. 35. Chen J. Pathogenicity and transmissibility of 2019-nCoV—a quick overview and comparison with other emerging viruses. Microbes and infection. 2020.
36. 36. Cleveland JL, Gray SK, Harte JA, Robison VA, Moorman AC, Gooch BF. Transmission of blood-borne pathogens in US dental health care settings: 2016 update. The Journal of the American Dental Association. 2016;147(9):729-38.
37. 37. Otter J, Donskey C, Yezli S, Douthwaite S, Goldenberg S, Weber D. Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. Journal of Hospital Infection. 2016;92(3):235-50.
38. 38. Meng L, Hua F, Bian Z. Coronavirus disease 2019 (COVID-19): emerging and future challenges for dental and oral medicine. Journal of Dental Research. 2020;99(5):481-7.
39. 39. Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. International Journal of Oral Science. 2020;12(1):1-5.
40. 40. Li Z, Meng L. The prevention and control of a new coronavirus infection in department of stomatology. Zhonghua kou Qiang yi xue za zhi= Zhonghua Kouqiang Yixue Zazhi= Chinese Journal of Stomatology. 2020;55:E001-E.
41. 41. Vandenberghe B, Jacobs R, Bosmans H. Modern dental imaging: a review of the current technology and clinical applications in dental practice. European radiology. 2010;20(11):2637-55.
42. 42. Bakanlığı TS, Müdürlüğü HSG. Covid-19 Rehberi. Mart; 2020.